美股新聞 標題聯播 · 近 24 小時 337 則 · 29 個來源 · 最新 9/20 04:53
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · HSIC近 30 天 13 則 · 第 1 / 1 頁
- Are Investors Undervaluing Henry Schein (HSIC) Right Now?
- What Makes Henry Schein (HSIC) a New Buy Stock
- HSIC or SAUHY: Which Is the Better Value Stock Right Now?
- DermaSensor Raises $5 Million and Opens Round to the Public via Wefunder, Alongside Four Major New US Partnerships
- Henry Schein to Participate in Upcoming Investor Conference in September
- Henry Schein (HSIC) is an Incredible Growth Stock: 3 Reasons Why
- Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report?
- Is Henry Schein (HSIC) Stock Undervalued Right Now?
- Henry Schein (HSIC) Looks Modestly Undervalued, Is More Upside Still Available?
- DermaSensor Announces Four Major New Industry Partnerships to Accelerate Growth in the US
- Growth Trajectory and Attractive Valuations Support Henry Schein’s (HSIC) Bullish Thesis
- Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental Market
- HSIC vs. SAUHY: Which Stock Is the Better Value Option?
- What Are Wall Street Analysts' Target Price for Henry Schein Stock?
- Is HSIC Worth Buying as Growth Improves but Execution Risks Persist?
- 3 Unpopular Stocks with Open Questions
- HSIC Raises 2026 Outlook as Sales and Margin Momentum Accelerates
- How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook
- 5 Insightful Analyst Questions From Henry Schein’s Q2 Earnings Call
- Henry Schein (HSIC) Q2 2026 Earnings Call Transcript
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。